Tyra Biosciences, Inc.

NasdaqGS:TYRA Stock Report

Market Cap: US$973.3m

Tyra Biosciences Balance Sheet Health

Financial Health criteria checks 6/6

Tyra Biosciences has a total shareholder equity of $204.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $225.9M and $21.6M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$203.47m
EquityUS$204.26m
Total liabilitiesUS$21.60m
Total assetsUS$225.86m

Recent financial health updates

Recent updates

We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate

Jan 13
We're Not Very Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Rate

We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth

Sep 27
We Think Tyra Biosciences (NASDAQ:TYRA) Can Afford To Drive Business Growth

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Jun 13
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Feb 23
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Nov 09
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans

Tyra Biosciences GAAP EPS of -$0.36

Aug 04

Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Jul 21
Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Mar 31
Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth

Dec 15
Companies Like Tyra Biosciences (NASDAQ:TYRA) Are In A Position To Invest In Growth

Financial Position Analysis

Short Term Liabilities: TYRA's short term assets ($211.7M) exceed its short term liabilities ($15.3M).

Long Term Liabilities: TYRA's short term assets ($211.7M) exceed its long term liabilities ($6.3M).


Debt to Equity History and Analysis

Debt Level: TYRA is debt free.

Reducing Debt: TYRA has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TYRA has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: TYRA has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 47.2% each year.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.